|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.640 USD | -7.87% |
|
-11.83% | -45.15% |
| 06-23 | Pluri Inc. Announces Board and Board Committee Changes | CI |
| 06-02 | Cellav Health and Aesthetics Ltd Completes Development and U.S. Cosmetic Product Listings of Regenativo+ and Placento+ | CI |
Company Valuation: Pluri Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 220.2 | 125.9 | 39.79 | 32.98 | 30.76 | 38.77 |
| Change | - | -42.83% | -68.39% | -17.11% | -6.74% | 26.06% |
| Enterprise Value (EV) 1 | 176 | 85.51 | 13.57 | 22.71 | 30.38 | 52.21 |
| Change | - | -51.41% | -84.13% | 67.33% | 33.77% | 71.84% |
| P/E | -5.52x | -2.23x | -0.96x | -1.04x | -1.45x | -1.39x |
| PBR | 4.02x | 2.21x | 1.33x | 2.48x | 326x | -5.71x |
| PEG | - | -0.2x | 0x | 0x | 0x | 0.1x |
| Capitalization / Revenue | 9,573x | - | 170x | 115x | 94.3x | 29x |
| EV / Revenue | 7,651x | - | 58x | 79.1x | 93.2x | 39.1x |
| EV / EBITDA | -6.31x | -1.74x | -0.33x | -0.84x | -1.39x | -2.39x |
| EV / EBIT | -5.97x | -1.69x | -0.33x | -0.83x | -1.37x | -2.35x |
| EV / FCF | -11.1x | -6.81x | -0.62x | -1.6x | -2.37x | -3.88x |
| FCF Yield | -9.03% | -14.7% | -161% | -62.5% | -42.2% | -25.7% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -12.82 | -14.19 | -10.25 | -6.182 | -3.986 | -3.564 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.023 | - | 0.234 | 0.287 | 0.326 | 1.336 |
| EBITDA 1 | -27.91 | -49.25 | -40.54 | -26.88 | -21.9 | -21.86 |
| EBIT 1 | -29.48 | -50.62 | -41.59 | -27.25 | -22.16 | -22.18 |
| Net income 1 | -29.15 | -49.86 | -41.24 | -28.32 | -20.89 | -22.58 |
| Net Debt 1 | -44.2 | -40.37 | -26.21 | -10.27 | -0.373 | 13.44 |
| Reference price 2 | 70.720 | 31.680 | 9.840 | 6.416 | 5.780 | 4.950 |
| Nbr of stocks (in thousands) | 3,113 | 3,973 | 4,043 | 5,140 | 5,321 | 7,833 |
| Announcement Date | 10/09/20 | 13/09/21 | 21/09/22 | 12/09/23 | 18/09/24 | 17/09/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 19.21M | |
| 32.25x | 5.76x | 17.3x | 1.02% | 46.86B | |
| -23.62x | 354.58x | -21.66x | -.--% | 40.23B | |
| 48.91x | 4.94x | 31.87x | -.--% | 36.23B | |
| 25.32x | 2.8x | 12.1x | -.--% | 34.72B | |
| 27.42x | 8.04x | 20.17x | 0.41% | 27.89B | |
| 34.31x | 5.61x | 25.58x | -.--% | 16.79B | |
| 22.12x | 1.95x | 8.48x | 1.19% | 13.12B | |
| 23.43x | 1.87x | 11.34x | -.--% | 12.7B | |
| Average | 23.77x | 48.19x | 13.15x | 0.33% | 25.4B | |
| Weighted average by Cap. | 22.49x | 66.41x | 12.08x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PLUR Stock
- Valuation Pluri Inc.
Select your edition
All financial news and data tailored to specific country editions
